Doctor profile · Federal record
Dr. Muhammad Siddiqui, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · McKinney, TX
- NPI 1194011999
- Accepts Medicare
- MIPS 74.1 / 100 · 2023
- 19 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
4521 Medical Center Dr Ste 400
McKinney, TX 750696863
(214) 547-7557
fax (469) 631-7217 - Additional location
-
4510 Medical Center Dr Ste 202
McKinney, TX 750691605 - Additional location
-
5309 W University Dr
McKinney, TX 750717824
(972) 562-1018
Credentials & registration
- NPI registered
- June 2011 — 15 yrs on file
- Profile last updated
- February 24, 2023
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #Q5278
- Medicaid
- TX #365886602
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194011999. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,228
Distinct HCPCS
10
Medicare allowed
$322,566
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 1,425 | 238 | $61 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 855 | 490 | $123 | |
99439 |
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 630 | 238 | $46 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 352 | 81 | $77 | |
99426 |
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 340 | 59 | $60 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 248 | 120 | $33 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 114 | 114 | $161 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 102 | 88 | $127 | |
99427 |
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 68 | 38 | $46 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 58 | 34 | $115 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 352. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$12,551
Transactions
94
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 21 | $7,499.86 | |
| Xeris Pharmaceuticals, Inc. | 8 | $2,867.98 | |
| CeQur Corporation | 2 | $620.07 | |
| Abbott Laboratories | 11 | $263.03 | |
| Lilly USA, LLC | 16 | $244.06 | |
| Tandem Diabetes Care, Inc. | 2 | $162.31 | |
| Mannkind Corporation | 8 | $140.05 | |
| Corcept Therapeutics | 4 | $114.34 | |
| Radius Health, Inc. | 5 | $94.23 | |
| Amgen Inc. | 4 | $69.46 | |
| IBSA Pharma Inc. | 3 | $63.91 | |
| Medtronic, Inc. | 2 | $55.62 | |
| Antares Pharma, Inc. | 3 | $52.64 | |
| BETA BIONICS, INC. | 3 | $51.74 | |
| Dexcom, Inc. | 2 | $46.82 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,746
Patients
977
Total drug cost
$2,247,110
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 540 | 181 | $7,518 |
| Ozempic (Semaglutide) | Brand | 499 | 156 | $961,764 |
| Metformin Hcl | Generic | 301 | 112 | $2,933 |
| Atorvastatin Calcium | Generic | 212 | 75 | $2,983 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 182 | 62 | $251,360 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 154 | 58 | $223,219 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 135 | 70 | $14,490 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 112 | 38 | $90,971 |
| Jardiance (Empagliflozin) | Brand | 110 | 37 | $172,580 |
| Trulicity (Dulaglutide) | Brand | 102 | 38 | $230,711 |
Frequently asked questions
What is Dr. Muhammad Siddiqui's medical specialty?
Dr. Muhammad Siddiqui practices Endocrinology, Diabetes & Metabolism Physician in McKinney, TX.
Where does Dr. Muhammad Siddiqui practice?
Dr. Muhammad Siddiqui practices at 4521 Medical Center Dr Ste 400, McKinney, TX 750696863. Office phone: 2145477557.
What is Dr. Muhammad Siddiqui's NPI?
Dr. Muhammad Siddiqui's National Provider Identifier (NPI) is 1194011999, issued by NPPES.
Does Dr. Muhammad Siddiqui accept Medicare assignment?
Yes. Dr. Muhammad Siddiqui accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Muhammad Siddiqui commonly perform?
Top Medicare-reported procedures in 2023: Chronic care management services (HCPCS 99490); Established patient office or other outpatient visit (HCPCS 99214); Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS 99439). Source: CMS Medicare Physician & Other Practitioners file.